[시장보고서]인플루엔자 백신 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2033년)

인플루엔자 백신 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2033년)

Flu Vaccines Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

상품코드 : 1537077

리서치사 : Persistence Market Research

발행일 : 2024년 08월

페이지 정보 : 영문 195 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,995

￦ 7,153,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295

￦ 10,447,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495

￦ 12,166,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

Persistence Market Research는 최근 세계 인플루엔자 백신 시장에 대한 종합적인 보고서를 발표했습니다. 이 보고서는 시장 촉진요인, 동향, 기회 및 과제를 포함한 주요 시장 역학을 철저히 평가하고 시장 구조에 대한 심층적인 인사이트를 제공합니다.

주요 인사이트

인플루엔자 백신 시장 규모(2024E) : 57억 5,000만 달러
예상 시장 규모(2033F) : 102억 달러
세계 시장 성장률(2024-2033년 CAGR) : 6.6%

인플루엔자 백신 시장 - 보고서 범위:

인플루엔자 백신은 계절성 독감을 예방하고 독감 유행의 영향을 줄이는 데 중요한 역할을 합니다. 인플루엔자 백신은 다양한 독감 바이러스 균주에 대한 방어력을 제공하며, 공중 보건에 필수적인 역할을 합니다. 인플루엔자 백신 시장은 의료 서비스 제공자, 병원, 진료소 및 공중 보건 기관을 대상으로 하며, 3가 백신, 4가 백신, 여러 독감 균주를 표적으로 하는 새로운 제형 등 다양한 유형의 백신을 제공합니다. 시장 성장의 원동력은 독감 예방에 대한 인식 증가, 의료비 지출 증가, 백신 기술의 발전으로 인한 백신의 효능과 안전성 향상입니다.

시장 성장 촉진요인:

세계 인플루엔자 백신 시장은 계절성 독감 예방과 의료비 부담 감소를 위한 백신 접종의 중요성에 대한 인식이 높아지는 등 몇 가지 중요한 요인에 의해 주도되고 있습니다. 특히 노인과 유아 등 사회적 약자의 독감 관련 합병증 발생률 증가는 시장 확대의 또 다른 원동력이 되고 있습니다. 고용량 백신 및 보조 백신 시장 개척과 같은 기술 발전은 예방 효과를 높이고 시장 성장을 촉진할 것입니다. 또한, 전 세계 정부 및 보건 기관의 백신 접종 프로그램 채택이 증가함에 따라 인플루엔자 백신에 대한 수요가 크게 증가하고 있습니다.

시장 억제요인:

유망한 성장 전망에도 불구하고 인플루엔자 백신 시장은 백신 접종에 대한 망설임, 높은 제조 비용, 규제 장애물 등의 문제에 직면해 있습니다. 백신의 안전성과 효능에 대한 우려는 백신 접종을 주저하게 만들고 백신 접종률과 시장 성장에 영향을 미칠 수 있습니다. 높은 제조 비용과 복잡한 제조 공정은 특히 중저소득 국가에서 백신의 접근성과 구매 용이성에 문제를 야기할 수 있습니다. 또한, 백신 승인 및 유통에 대한 규제 요건은 제조업체의 업무 복잡성을 야기하고 시장 역학에 영향을 미치고 있습니다.

시장 기회:

인플루엔자 백신 시장은 기술 혁신, 인구 동향, 진화하는 의료 서비스 제공 모델로 인해 큰 성장 기회를 맞이하고 있습니다. 여러 균주를 표적으로 삼고 예방 효과가 더 오래 지속되는 백신 등 새로운 백신 제제의 시장 개척이 시장 잠재력을 높이고 있습니다. 또한, 종합적인 예방접종 프로그램 및 공중보건 이니셔티브와의 제휴 등 예방 보건 전략에서 인플루엔자 백신의 적용 범위가 확대되면서 시장 범위가 넓어지고 있습니다. R&D에 대한 전략적 투자와 의료 서비스 제공자 및 정부 기관과의 협력은 새로운 기회를 활용하고 시장 성장을 유지하기 위해 필수적입니다.

본 보고서에서 다루는 주요 질문들

세계 인플루엔자 백신 시장의 성장을 촉진하는 주요 요인은 무엇인가?
각 지역에서 인플루엔자 백신의 채택에 기여하는 백신의 종류와 제형은 무엇인가?
기술 발전은 인플루엔자 백신 시장의 경쟁 구도를 어떻게 변화시키고 있는가?
인플루엔자 백신 시장에 기여하는 주요 플레이어는 누구이며, 시장의 관련성을 유지하기 위해 어떤 전략을 취하고 있는가?
세계 인플루엔자 백신 시장의 새로운 트렌드와 향후 전망은?

소개/주요 조사 결과
시장 규모(금액) 분석, 2019-2023년
시장 규모(금액) 분석과 예측, 2024-2033년
- 기관투자가용 판매
  - 병원
  - 커뮤니티 클리닉
  - 공중위생 기관
  - 직장 구매
- 소매 판매
  - 소매 약국
  - 통신 판매 약국
유통 채널별 시장 매력 분석

제13장 지역별 : 세계 시장 분석

소개
시장 규모(금액 및 수량) 분석, 2019-2023년
시장 규모(금액 및 수량) 분석과 예측, 2024-2033년
- 북미
- 라틴아메리카
- 유럽
- 동아시아
- 남아시아
- 오세아니아
- 중동 및 아프리카(MEA)
지역별 시장 매력 분석

제14장 북미 시장 분석

제15장 라틴아메리카 시장 분석

제16장 유럽 시장 분석

제17장 동아시아 시장 분석

제18장 남아시아 시장 분석

제19장 오세아니아 시장

제20장 중동 및 아프리카 시장 분석

제21장 시장 구조 분석

기업 계층별 시장 분석
주요 기업의 시장 점유율 분석
시장 입지 분석

제22장 경쟁 분석

경쟁 대시보드
경쟁 벤치마크
경쟁 상세
- Sanofi Pasteur Inc.
- Astrazeneca
- Csl Ltd.
- Abbbott
- Glaxosmithkline Plc.
- Serum Institute of India Pvt.Ltd

제23장 사용되는 가정과 두문자어

제24장 조사 방법

ksm

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the worldwide market for flu vaccines. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

Flu Vaccines Market Size (2024E): USD 5.75 Billion
Projected Market Value (2033F): USD 10.2 Billion
Global Market Growth Rate (CAGR 2024 to 2033): 6.6%

Flu Vaccines Market - Report Scope:

Flu vaccines play a crucial role in preventing seasonal influenza and reducing the impact of flu outbreaks. These vaccines are essential for public health, offering protection against various strains of influenza viruses. The flu vaccines market caters to healthcare providers, hospitals, clinics, and public health organizations, offering a range of vaccine types, including trivalent and quadrivalent vaccines, as well as newer formulations targeting multiple flu strains. Market growth is driven by increasing awareness of influenza prevention, rising healthcare expenditures, and advancements in vaccine technology, enhancing vaccine efficacy and safety.

Market Growth Drivers:

The global flu vaccines market is propelled by several key factors, including growing awareness about the importance of vaccination in preventing seasonal flu and reducing healthcare burdens. The increasing incidence of influenza-related complications, particularly among vulnerable populations such as the elderly and young children, further drives market expansion. Technological advancements, such as the development of high-dose and adjuvanted vaccines, offer improved protection and stimulate market growth. Additionally, the rising adoption of vaccination programs by governments and health organizations worldwide creates a substantial demand for flu vaccines.

Market Restraints:

Despite promising growth prospects, the flu vaccines market faces challenges related to vaccine hesitancy, high production costs, and regulatory hurdles. Vaccine hesitancy, driven by concerns about vaccine safety and efficacy, can impact vaccination rates and market growth. High production costs and complex manufacturing processes pose challenges for vaccine accessibility and affordability, particularly in low- and middle-income countries. Additionally, regulatory requirements for vaccine approval and distribution create operational complexities for manufacturers, affecting market dynamics.

Market Opportunities:

The flu vaccines market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. The development of new vaccine formulations, including those targeting multiple strains and offering longer protection, enhances market potential. Furthermore, the expanding application of flu vaccines in preventive health strategies, such as integrated vaccination programs and partnerships with public health initiatives, broadens market scope. Strategic investments in research and development, along with collaborations with healthcare providers and governmental agencies, are essential to capitalize on emerging opportunities and sustain market growth.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the flu vaccines market globally?
Which vaccine types and formulations are contributing to the adoption of flu vaccines across different regions?
How are technological advancements reshaping the competitive landscape of the flu vaccines market?
Who are the key players contributing to the flu vaccines market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global flu vaccines market?

Competitive Intelligence and Business Strategy:

Leading players in the global flu vaccines market, including GlaxoSmithKline plc, Pfizer Inc., Sanofi Pasteur, and AstraZeneca, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced vaccine formulations, including high-dose and adjuvanted vaccines, catering to diverse patient needs and public health requirements. Collaborations with governmental health agencies, public health organizations, and research institutions facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practices, and public education enhances market growth and vaccination uptake in the dynamic flu vaccines landscape.

Key Companies Profiled:

Sanofi Pasteur Inc.
AstraZeneca
Csl Ltd.
Abbott
GlaxoSmithKline Plc.
Serum Institute Of India Pvt.Ltd

Key Segments Covered in Flu Vaccines Industry Research

Product:

Trivalent Flu Vaccine
Quadrivalent Flu Vaccine

Dosage Form:

Intramuscular Injection
Nasal Spray
Intradermal Shot

Distribution Channel:

Institutional Sales
Retail Sales

Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends

4. Value Added Insights

4.1. Production Strategy
4.2. Volume Consumption
4.3. Production Cost
4.4. Pipeline Assessment
4.5. Patent Analysis
4.6. PESTEL Analysis
4.7. Porter's Analysis

5. Market Background

5.1. Macro-Economic Factors
- 5.1.1. Global GDP Growth Outlook
- 5.1.2. Global Healthcare Outlook
- 5.1.3. Growing government support and focus for the development of the vaccines
5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Development of Vaccine Products
- 5.2.2. Regulatory Imposition
- 5.2.3. Increasing Expenditure on Research and Development
- 5.2.4. Increasing Prevalence of Seasonal Flu
- 5.2.5. Increased Vaccination Rates
- 5.2.6. High Rate of Manufacturing
- 5.2.7. Strategic Mergers and Acquisitions Among Local Manufacturers
5.3. Market Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

6.1. COVID-19 and Impact Analysis
6.2. 2024 Market Scenario

7. Global Market Volume (Units) Analysis 2019-2023 and Forecast, 2024-2033

7.1. Historical Market Volume (Units) Analysis, 2019-2023
7.2. Current and Future Market Volume (Units) Projections, 2024-2033
- 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market- Pricing Analysis

8.1. Regional Pricing Analysis By Product
8.2. Price Break up
- 8.2.1. Manufacturer Level
- 8.2.2. Distributor Level
8.3. Global Average Pricing Analysis Benchmark
- 8.3.1. Pricing Assumptions

9. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

9.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
9.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
- 9.2.1. Y-o-Y Growth Trend Analysis
- 9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Product, 2019-2023
10.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Product, 2024-2033
- 10.3.1. Trivalent Flu Vaccine
- 10.3.2. Quadrivalent Flu Vaccine
10.4. Market Attractiveness Analysis By Product

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Dosage Form

11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Bn) Analysis, By Dosage Form, 2019-2023
11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Dosage Form, 2024-2033
- 11.3.1. Intramuscular Injection
- 11.3.2. Nasal Spray
- 11.3.3. Intradermal Shot
11.4. Market Attractiveness Analysis By Dosage Form

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Distribution Channels

12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Bn) Analysis, By Distribution Channels, 2019-2023
12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Distribution Channels, 2024-2033
- 12.3.1. Institutional Sales
  - 12.3.1.1. Hospitals
  - 12.3.1.2. Community Clinics
  - 12.3.1.3. Public Health Agencies
  - 12.3.1.4. Workplace Purchasing
- 12.3.2. Retail Sales
  - 12.3.2.1. Retail Pharmacies
  - 12.3.2.2. Mail Order Pharmacies
12.4. Market Attractiveness Analysis By Distribution Channels

13. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

13.1. Introduction
13.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Region, 2019-2023
13.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
- 13.3.1. North America
- 13.3.2. Latin America
- 13.3.3. Europe
- 13.3.4. East Asia
- 13.3.5. South Asia
- 13.3.6. Oceania
- 13.3.7. Middle East and Africa (Middle East and Africa)
13.4. Market Attractiveness Analysis By Region

14. North America Market Analysis 2019-2023 and Forecast 2024-2033

14.1. Introduction
14.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
14.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
- 14.3.1. By Country
  - 14.3.1.1. U.S.
  - 14.3.1.2. Canada
- 14.3.2. By Product
- 14.3.3. By Dosage Form
- 14.3.4. By Distribution Channels
14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Product
- 14.4.3. By Dosage Form
- 14.4.4. By Distribution Channels
14.5. Market Trends
14.6. Drivers and Restraints - Impact Analysis
14.7. Key Players - Intensity Mapping
14.8. Country Level Analysis & Forecast
- 14.8.1. U.S. Market Analysis
  - 14.8.1.1. Introduction
  - 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.1.2.1. By Product
    - 14.8.1.2.2. By Dosage Form
    - 14.8.1.2.3. By Distribution Channels
- 14.8.2. Canada Market Analysis
  - 14.8.2.1. Introduction
  - 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.2.2.1. By Product
    - 14.8.2.2.2. By Dosage Form
    - 14.8.2.2.3. By Distribution Channels

15. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

15.1. Introduction
15.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
15.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
- 15.3.1. By Country
  - 15.3.1.1. Mexico
  - 15.3.1.2. Brazil
  - 15.3.1.3. Argentina
  - 15.3.1.4. Rest of Latin America
- 15.3.2. By Product
- 15.3.3. By Dosage Form
- 15.3.4. By Distribution Channels
15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Product
- 15.4.3. By Dosage Form
- 15.4.4. By Distribution Channels
15.5. Market Trends
15.6. Drivers and Restraints - Impact Analysis
15.7. Key Players - Intensity Mapping
15.8. Country Level Analysis & Forecast
- 15.8.1. Mexico Market Analysis
  - 15.8.1.1. Introduction
  - 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.1.2.1. By Product
    - 15.8.1.2.2. By Dosage Form
    - 15.8.1.2.3. By Distribution Channels
- 15.8.2. Brazil Market Analysis
  - 15.8.2.1. Introduction
  - 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.2.2.1. By Product
    - 15.8.2.2.2. By Dosage Form
    - 15.8.2.2.3. By Distribution Channels
- 15.8.3. Argentina Market Analysis
  - 15.8.3.1. Introduction
  - 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.3.2.1. By Product
    - 15.8.3.2.2. By Dosage Form
    - 15.8.3.2.3. By Distribution Channels

16. Europe Market Analysis 2019-2023 and Forecast 2024-2033

16.1. Introduction
16.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
16.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
- 16.3.1. By Country
  - 16.3.1.1. Germany
  - 16.3.1.2. Italy
  - 16.3.1.3. France
  - 16.3.1.4. U.K.
  - 16.3.1.5. Spain
  - 16.3.1.6. BENELUX
  - 16.3.1.7. Russia
  - 16.3.1.8. Rest of Europe
- 16.3.2. By Product
- 16.3.3. By Dosage Form
- 16.3.4. By Distribution Channels
16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Product
- 16.4.3. By Dosage Form
- 16.4.4. By Distribution Channels
16.5. Market Trends
16.6. Drivers and Restraints - Impact Analysis
16.7. Key Players - Intensity Mapping
16.8. Country Level Analysis & Forecast
- 16.8.1. Germany Market Analysis
  - 16.8.1.1. Introduction
  - 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.1.2.1. By Product
    - 16.8.1.2.2. By Dosage Form
    - 16.8.1.2.3. By Distribution Channels
- 16.8.2. Italy Market Analysis
  - 16.8.2.1. Introduction
  - 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.2.2.1. By Product
    - 16.8.2.2.2. By Dosage Form
    - 16.8.2.2.3. By Distribution Channels
- 16.8.3. France Market Analysis
  - 16.8.3.1. Introduction
  - 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.3.2.1. By Product
    - 16.8.3.2.2. By Dosage Form
    - 16.8.3.2.3. By Distribution Channels
- 16.8.4. U.K. Market Analysis
  - 16.8.4.1. Introduction
  - 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.4.2.1. By Product
    - 16.8.4.2.2. By Dosage Form
    - 16.8.4.2.3. By Distribution Channels
- 16.8.5. Spain Market Analysis
  - 16.8.5.1. Introduction
  - 16.8.5.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.5.2.1. By Product
    - 16.8.5.2.2. By Dosage Form
    - 16.8.5.2.3. By Distribution Channels
- 16.8.6. BENELUX Market Analysis
  - 16.8.6.1. Introduction
  - 16.8.6.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.6.2.1. By Product
    - 16.8.6.2.2. By Dosage Form
    - 16.8.6.2.3. By Distribution Channels
- 16.8.7. Russia Market Analysis
  - 16.8.7.1. Introduction
  - 16.8.7.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.7.2.1. By Product
    - 16.8.7.2.2. By Dosage Form
    - 16.8.7.2.3. By Distribution Channels

17. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

17.1. Introduction
17.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
17.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
- 17.3.1. By Country
  - 17.3.1.1. China
  - 17.3.1.2. Japan
  - 17.3.1.3. South Korea
- 17.3.2. By Product
- 17.3.3. By Dosage Form
- 17.3.4. By Distribution Channels
17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Product
- 17.4.3. By Dosage Form
- 17.4.4. By Distribution Channels
17.5. Market Trends
17.6. Drivers and Restraints - Impact Analysis
17.7. Key Players - Intensity Mapping
17.8. Country Level Analysis & Forecast
- 17.8.1. China Market Analysis
  - 17.8.1.1. Introduction
  - 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.1.2.1. By Product
    - 17.8.1.2.2. By Dosage Form
    - 17.8.1.2.3. By Distribution Channels
- 17.8.2. Japan Market Analysis
  - 17.8.2.1. Introduction
  - 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.2.2.1. By Product
    - 17.8.2.2.2. By Dosage Form
    - 17.8.2.2.3. By Distribution Channels
- 17.8.3. South Korea Market Analysis
  - 17.8.3.1. Introduction
  - 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.3.2.1. By Product
    - 17.8.3.2.2. By Dosage Form
    - 17.8.3.2.3. By Distribution Channels

18. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

18.1. Introduction
18.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
18.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
- 18.3.1. By Country
  - 18.3.1.1. India
  - 18.3.1.2. Indonesia
  - 18.3.1.3. Malaysia
  - 18.3.1.4. Thailand
  - 18.3.1.5. Rest of South Asia
- 18.3.2. By Product
- 18.3.3. By Dosage Form
- 18.3.4. By Distribution Channels
18.4. Market Attractiveness Analysis
- 18.4.1. By Country
- 18.4.2. By Product
- 18.4.3. By Dosage Form
- 18.4.4. By Distribution Channels
18.5. Market Trends
18.6. Drivers and Restraints - Impact Analysis
18.7. Key Players - Intensity Mapping
18.8. Country Level Analysis & Forecast
- 18.8.1. India Market Analysis
  - 18.8.1.1. Introduction
  - 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 18.8.1.2.1. By Product
    - 18.8.1.2.2. By Dosage Form
    - 18.8.1.2.3. By Distribution Channels
- 18.8.2. Indonesia Market Analysis
  - 18.8.2.1. Introduction
  - 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 18.8.2.2.1. By Product
    - 18.8.2.2.2. By Dosage Form
    - 18.8.2.2.3. By Distribution Channels
- 18.8.3. Malaysia Market Analysis
  - 18.8.3.1. Introduction
  - 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 18.8.3.2.1. By Product
    - 18.8.3.2.2. By Dosage Form
    - 18.8.3.2.3. By Distribution Channels
- 18.8.4. Thailand Market Analysis
  - 18.8.4.1. Introduction
  - 18.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 18.8.4.2.1. By Product
    - 18.8.4.2.2. By Dosage Form
    - 18.8.4.2.3. By Distribution Channels

19. Oceania Market 2019-2023 and Forecast 2024-2033

19.1. Introduction
19.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
19.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
- 19.3.1. By Country
  - 19.3.1.1. Australia
  - 19.3.1.2. New Zealand
- 19.3.2. By Product
- 19.3.3. By Dosage Form
- 19.3.4. By Distribution Channels
19.4. Market Attractiveness Analysis
- 19.4.1. By Country
- 19.4.2. By Product
- 19.4.3. By Dosage Form
- 19.4.4. By Distribution Channels
19.5. Market Trends
19.6. Drivers and Restraints - Impact Analysis
19.7. Key Players - Intensity Mapping
19.8. Country Level Analysis & Forecast
- 19.8.1. Australia Market Analysis
  - 19.8.1.1. Introduction
  - 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 19.8.1.2.1. By Product
    - 19.8.1.2.2. By Dosage Form
    - 19.8.1.2.3. By Distribution Channels
- 19.8.2. New Zealand Market Analysis
  - 19.8.2.1. Introduction
  - 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 19.8.2.2.1. By Product
    - 19.8.2.2.2. By Dosage Form
    - 19.8.2.2.3. By Distribution Channels

20. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033

20.1. Introduction
20.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
20.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
- 20.3.1. By Country
  - 20.3.1.1. GCC Countries
  - 20.3.1.2. Turkiye
  - 20.3.1.3. North Africa
  - 20.3.1.4. South Africa
  - 20.3.1.5. Rest of Middle East and Africa
- 20.3.2. By Product
- 20.3.3. By Dosage Form
- 20.3.4. By Distribution Channels
20.4. Market Attractiveness Analysis
- 20.4.1. By Country
- 20.4.2. By Product
- 20.4.3. By Dosage Form
- 20.4.4. By Distribution Channels
20.5. Market Trends
20.6. Drivers and Restraints - Impact Analysis
20.7. Key Players - Intensity Mapping
20.8. Country Level Analysis & Forecast
- 20.8.1. GCC Countries Market Analysis
  - 20.8.1.1. Introduction
  - 20.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 20.8.1.2.1. By Product
    - 20.8.1.2.2. By Dosage Form
    - 20.8.1.2.3. By Distribution Channels
- 20.8.2. Turkiye Market Analysis
  - 20.8.2.1. Introduction
  - 20.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 20.8.2.2.1. By Product
    - 20.8.2.2.2. By Dosage Form
    - 20.8.2.2.3. By Distribution Channels
- 20.8.3. South Africa Market Analysis
  - 20.8.3.1. Introduction
  - 20.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 20.8.3.2.1. By Product
    - 20.8.3.2.2. By Dosage Form
    - 20.8.3.2.3. By Distribution Channels
- 20.8.4. North Africa Market Analysis
  - 20.8.4.1. Introduction
  - 20.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 20.8.4.2.1. By Product
    - 20.8.4.2.2. By Dosage Form
    - 20.8.4.2.3. By Distribution Channels

21. Market Structure Analysis

21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis

22. Competition Analysis

22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
- 22.3.1. Sanofi Pasteur Inc.
  - 22.3.1.1. Overview
  - 22.3.1.2. Product Portfolio
  - 22.3.1.3. Sales Footprint
  - 22.3.1.4. Key Financials
  - 22.3.1.5. SWOT Analysis
  - 22.3.1.6. Strategy Overview
- 22.3.2. Astrazeneca
  - 22.3.2.1. Overview
  - 22.3.2.2. Product Portfolio
  - 22.3.2.3. Sales Footprint
  - 22.3.2.4. Key Financials
  - 22.3.2.5. SWOT Analysis
  - 22.3.2.6. Strategy Overview
- 22.3.3. Csl Ltd.
  - 22.3.3.1. Overview
  - 22.3.3.2. Product Portfolio
  - 22.3.3.3. Sales Footprint
  - 22.3.3.4. Key Financials
  - 22.3.3.5. SWOT Analysis
  - 22.3.3.6. Strategy Overview
- 22.3.4. Abbbott
  - 22.3.4.1. Overview
  - 22.3.4.2. Product Portfolio
  - 22.3.4.3. Sales Footprint
  - 22.3.4.4. Key Financials
  - 22.3.4.5. SWOT Analysis
  - 22.3.4.6. Strategy Overview
- 22.3.5. Glaxosmithkline Plc.
  - 22.3.5.1. Overview
  - 22.3.5.2. Product Portfolio
  - 22.3.5.3. Sales Footprint
  - 22.3.5.4. Key Financials
  - 22.3.5.5. SWOT Analysis
  - 22.3.5.6. Strategy Overview
- 22.3.6. Serum Institute of India Pvt.Ltd
  - 22.3.6.1. Overview
  - 22.3.6.2. Product Portfolio
  - 22.3.6.3. Sales Footprint
  - 22.3.6.4. Key Financials
  - 22.3.6.5. SWOT Analysis
  - 22.3.6.6. Strategy Overview